基因代理瘦身量和阿尔茨海默病风险:孟德尔随机化研究
Iyas Daghlas1, Malik Nassan2, Dipender Gill3,4
1Department of Neurology, University of California San Francisco, San Francisco, California, USA.
BMJ medicine
|August 11, 2023
概括
更高的瘦身量与阿尔茨海默病风险降低有关. 这表明瘦身量可能是预防阿尔茨海默病的可修改因素.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 阿尔茨海默病 (AD) 构成了全球重大健康挑战.
- 确定可修改的风险因素对于AD预防策略至关重要.
研究的目的:
- 调查遗传代理瘦体和患阿尔茨海默病的风险之间的关联.
- 探索瘦体和认知表现之间的关系.
主要方法:
- 一项孟德尔的随机化研究,利用来自英国生物库的总结级遗传数据和大型全基因组关联研究.
- 分析包括超过45万名参与者进行瘦身量测量和AD和认知表现的独立队列.
主要成果:
- 基因代理的尾瘦质量增加1个标准偏差与阿尔茨海默病风险降低12%有关 (OR0.88,P=0.001).
- 这种关联在一个独立的队列中得到复制,并在敏感性分析中保持一致.
- 更高的基因代理瘦身量也与更好的认知表现有关 (0.09 SD增加,P=0.001).
结论:
- 基因决定的瘦体质似乎是对阿尔茨海默病的保护因素.
- 瘦身量可能代表一个潜在的可修改的目标,用于AD预防.
- 需要进一步的研究来阐明潜在的机制和临床影响.
相关概念视频
01:28Human Genetics
612
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
612
01:26Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521